Approval · Notice of Compliance 32329 · 2023
TEMBEXA: Notice of Compliance 32329
Issued December 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32329
- Date
- December 11, 2023
- Company
- Emergent Biodefense Operations Lansing LlcLansing, Michigan, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- BRINCIDOFOVIR 100 MG per TAB
- BRINCIDOFOVIR 10 MG per ML